Continuous Glucose Monitor Biosensor (14-Day Wear)
A wearable continuous glucose sensor that streams glucose trends to your phone. Clinical benefit is well established in diabetes; for metabolically healthy people it is best seen as an educational feedback tool.
Resar evidence panel
0–100 · cited research only
Evidence Score
58
Good
Safety Score
66
Good
Effectiveness Score
61
Good
Research Confidence
73
Strong
Product Fit Score
48
Emerging
Bottom line
Limited evidence (Good) — treat claims cautiously and review sources directly.
Product fit is weaker — dose, price, or practical use may not align with what studies tested.
Evidence Score
58
Good
Price
$89.00
Resar may earn an affiliate commission on this purchase. Commissions never change scores — see our affiliate disclosure and conflicts policy. Scores reflect cited research, not medical advice.
Compare others in Biomarker TestingTop research
The strongest studies behind this product
Ranked by evidence hierarchy and how closely each study matches this product. Start with the strongest study, then read down. Every claim needs a trail.
Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial
Randomized Controlled Trial · JAMA · 2017 · n=158
What the research shows
Clear improvement in glycemic control in an insulin-treated population.
Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: The MOBILE Randomized Clinical Trial
Randomized Controlled Trial · JAMA · 2021 · n=175
Glucotypes reveal new patterns of glucose dysregulation
Observational · PLOS Biology · 2018 · n=57
Scores reflect these cited studies, not medical advice. Expand the full evidence detail below for protocols, dose context, and reported side effects.
Did this clinical breakdown make sense?
Share this evidence report
Send a link to this page so others can read the same breakdown.
Claim ledger
Every claim, mapped to its source
Each product claim below is tied to a specific paper with study type, match strength, and limitations. Nothing here is medical advice — it is a research trail you can audit.
Claim match reflects how closely a specific paper supports this benefit — not AI confidence or medical certainty.
Full evidence detail
Study-by-study breakdown
Each paper below is ranked for this listing. Start with the highest match, then expand any study for a plain-language readout.
How to read this section
- Match % - how closely the study matches this product (not overall scientific quality).
- Evidence type - study design (RCT, review, etc.) and whether it is direct, category-level, or indirect.
- What it found - short summary and quoted extract from the paper metadata. Not medical advice.
In plain language
What the study reported
Verified extract — not AI generated
“Clear improvement in glycemic control in an insulin-treated population.”
Continuous wear with sensor changes roughly every 1-2 weeks.
Minor skin irritation at sensor sites; no serious device-related harms.
Caveats
Population had diagnosed diabetes; does not establish benefit in healthy people.
Transparency
Score history
Human review is pending for this listing.
Reviews
Shopper feedback
4.2
average rating
640 Amazon reviews were available from the listing metadata.